Background illustration for clinical trials search

Paid Clinical Trials Memphis

Discover 522 paid clinical trials in Memphis, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults

for
Chronic Idiopathic Constipation (CIC)
Location: Memphis TN, North Little Rock AR, Nashville TN,
Sponsor: Ardelyx

Sex: All

Age: 18 - 70+

Code: NCT07382167

Phase3, Recruiting

A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older

for
Clostridoides Difficile Associated Disease
Location: Memphis TN, Little Rock AR, Athens AL, Nashville TN,
Sponsor: Pfizer

Sex: All

Age: 65+

Code: NCT07282665

Phase3, Recruiting

A Study of NTX-1472 in Social Anxiety Disorder

for
Social Anxiety Disorder (SAD)
Location: Memphis TN, Austin TX, Jacksonville FL, Tampa FL,
Sponsor: Newleos Therapeutics, Inc.

Sex: All

Age: 18 - 65

Code: NCT07323784

Phase2, Recruiting

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

for
Metastatic Colorectal Cancer (CRC)
Location: Germantown TN, Tuscaloosa AL, Hermitage TN,
Sponsor: Summit Therapeutics

Sex: All

Age: 18+

Code: NCT07228832

Phase3, Recruiting

A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)

for
Bipolar Disorder, Bipolar Depression, Bipolar I Disorder,
Location: Memphis TN, Little Rock AR, Rogers AR, O'Fallon MO,
Sponsor: Xenon Pharmaceuticals Inc.

Sex: All

Age: 18 - 70+

Code: NCT07172516

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.

for
Hypertension (HTN)
Location: Memphis TN, Jefferson City MO, Fayetteville GA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07543120

Phase2, Recruiting

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes

for
Diabetes Mellitus, Type 2
Location: Memphis TN, Springfield MO, Dallas TX, Dayton OH,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 18 - 70+

Code: NCT07415954

Phase2, Recruiting

Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol

for
Binge-Eating Disorder
Location: Memphis TN, Saint Charles MO, Marietta GA,
Sponsor: Axsome Therapeutics, Inc.

Sex: All

Age: 18 - 55

Code: NCT06413433

Phase3, Recruiting

A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis

for
Primary Biliary Cholangitis (PBC)
Location: Cordova TN, Shreveport LA, Dallas TX, Arlington TX,
Sponsor: Ipsen

Sex: All

Age: 18+

Code: NCT06016842

Phase3, Recruiting

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

for
Age-related Macular Degeneration (AMD), Geographic Atrophy (GA)
Location: Southaven MS, Madison MS, Nashville TN, West Monroe LA,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 50 - 70+

Code: NCT06541704

Phase3, Recruiting

Evaluation of TL-925 for the Treatment of Allergic Conjunctivitis

for
Allergic Conjunctivitis
Location: Memphis TN
Sponsor: Telios Pharma, Inc.

Sex: All

Age: 18+

Code: NCT06686472

Phase2, Recruiting

Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol

for
Hypertriglyceridemia
Location: Memphis TN, St Louis MO, Springfield IL,
Sponsor: Marea Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07028749

Phase2, Recruiting

Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease

for
Graves Disease
Location: Memphis TN, Chattanooga TN, Springfield IL, Atlanta GA,
Sponsor: Biohaven Therapeutics Ltd.

Sex: All

Age: 18 - 70

Code: NCT07661056

Phase3, Recruiting

An Eight-Week Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye

for
Dry Eye
Location: Memphis TN, Newport Beach CA
Sponsor: Vanda Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07179055

Phase2, Recruiting

Study of BHV-1300 in Graves' Disease

for
Graves Disease
Location: Memphis TN, Columbus GA, Dallas TX, Houston TX,
Sponsor: Biohaven Therapeutics Ltd.

Sex: All

Age: 18 - 65

Code: NCT06980649

Phase1, Recruiting

Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic Disease Activity

for
Primary Sjögren's Syndrome
Location: Memphis TN, Jackson TN, New Orleans LA, Lake Charles LA,
Sponsor: Immunovant Sciences GmbH

Sex: All

Age: 18 - 70+

Code: NCT06979531

Phase2, Recruiting

A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

for
Graves' Disease
Location: Memphis TN, St Louis MO, Jefferson City MO,
Sponsor: Immunovant Sciences GmbH

Sex: All

Age: 18 - 70+

Code: NCT07018323

Phase2, Recruiting

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

for
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma,
Location: Memphis TN, Hot Springs AR, Nashville TN, Jackson MS,
Sponsor: Sameek Roychowdhury

Sex: All

Age: 18+

Code: NCT06906562

Phase2, Recruiting

An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

for
Cardiovascular Disease and Lipoprotein(a)
Location: Southaven MS, Germantown TN, Jackson TN, Little Rock AR,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07517263

Phase3, Recruiting

Pelacarsen Roll-over Extension Program

for
Atherosclerotic Cardiovascular Disease
Location: Southaven MS, Jackson TN, Little Rock AR,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT06875973

Phase3, Recruiting